Global X Copper Miners ETF vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Global X Copper Miners ETF trades at $84.47 (market cap $7.10B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.2 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 3.6× Global X Copper Miners ETF's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Global X Copper Miners ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Global X Copper Miners ETF for 50 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| COPX | RPRX | |
|---|---|---|
Market Cap | $7.10B | $25.27B |
Volume | 2,871,128 | 3,671,183 |
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $96.45 | $63.96 |
52-Week Low | $57.43 | $35.44 |
Typical Hold Time | 50 Days | 0 Days |
Enterprise Value | — | $32.50B |
Dividend Yield | — | 1.66% |
Signals from Pluang's Aura AI — not financial advice
COPX (Global X Copper Miners ETF) is trading at $83.58, down 3.13% with a bearish technical signal. The ETF faces selling pressure with 15 sell signals versus 2 buy signals across technical indicators. Copper fundamentals remain strong with prices near all-time highs above $6.85 per pound, driven by AI infrastructure demand and supply constraints. Recent news highlights copper's critical role in electrification and AI infrastructure, though technical indicators suggest near-term weakness.
The long-term copper thesis remains compelling due to structural supply deficits and AI-driven demand growth. However, near-term risks include potential Federal Reserve policy impacts and mining equity underperformance relative to copper prices. The ETF offers operational leverage to copper prices but faces volatility from global surplus projections and macroeconomic factors.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
COPX tracks the Solactive Global Copper Miners Total Return Index, providing broad exposure to companies worldwide involved in copper mining, refining, and exploration. It serves as an equity-based alternative to copper futures, offering a leveraged play on copper demand driven by global infrastructure and the clean energy transition.
Read more on COPX →Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →